MedPath

Dimethyl Sulfoxide

Generic Name
Dimethyl Sulfoxide
Brand Names
Rimso-50
Drug Type
Small Molecule
Chemical Formula
C2H6OS
CAS Number
67-68-5
Unique Ingredient Identifier
YOW8V9698H

Overview

A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during cryopreservation. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.

Background

A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during cryopreservation. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.

Indication

⑴作透皮促进剂,常用于氢化可的松、地塞米松、氟轻松、睾酮、胰岛素、肝素、维生素类、水杨酸类等的制剂。5%以下无透皮作用,5%以上随浓度增加而作用增强,常用其30%~50%水溶液。目前仅供外用。 ⑵作溶剂和防冻剂,60%水溶液能降低冰点至-80℃。

Associated Conditions

  • Interstitial Cystitis

Research Report

Published: May 13, 2025

Dimethyl Sulfoxide

  • Name: Dimethyl Sulfoxide
  • Name (English): Dimethyl Sulfoxide
  • DrugBank ID: DB01093
  • Type: Small Molecule
  • CAS Number: 67-68-5

Pharmacology:

  • Mechanism of Action: Multiple mechanisms including membrane penetration, membrane transport, effects on connective tissue, anti-inflammation, nerve blockade (analgesia), bacteriostasis, diuresis, enhancement or reduction of the effectiveness of other substances, induction of differentiation of malignant cells, radioprotective and cryoprotective actions, and protection against ischemic injury. It can also modulate cell membrane structure and properties, scavenge free radicals, and influence signal transduction pathways and gene expression.
  • Therapeutic Uses: Treatment of interstitial cystitis (intravesical administration). Topical use (not always FDA-approved) for pain relief, accelerating healing of wounds, burns, muscle and skeletal injuries, and treating conditions like osteoarthritis and rheumatoid arthritis. Also used to prevent soft tissue damage from IV chemotherapeutic agents (topical).

Pharmacokinetics:

  • Absorption: Well absorbed topically and rapidly penetrates tissues.
  • Metabolism: Oxidized to dimethyl sulfone and reduced to dimethyl sulfide.
  • Excretion: Urine and feces (as unchanged drug and dimethyl sulfone), with some elimination via skin and lungs (dimethyl sulfide).

Side Effects:

  • Common: Garlic-like taste in the mouth, garlic odor on breath and skin, bladder pain or discomfort.
  • Less Common/Serious: Rash, blistering, burning, redness, scaling, hives, itching, swelling of the face, lips, tongue, or throat, shortness of breath, dizziness, nausea, vomiting, headache, nasal congestion, vision changes, severe dizziness, altered heart rate, chest pain, confusion, slurred speech, weakness, loss of coordination, fever, tremors, severe eye or heart symptoms. Anaphylaxis and severe infusion reactions can occur.

Continue reading the full research report

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2019/01/24
Phase 4
Completed
2018/10/23
Phase 2
Completed
Dennis Bregner Zetner
2017/04/06
Early Phase 1
Completed
2015/01/13
Phase 1
Completed
2014/08/01
Phase 2
UNKNOWN
2010/02/24
Not Applicable
UNKNOWN
2010/02/17
Not Applicable
UNKNOWN
2008/04/25
Phase 3
Terminated
2006/04/24
Phase 2
Terminated
2005/07/11
Phase 1
Completed
Craig L Slingluff, Jr

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Zoetis Inc.
54771-0120
AURICULAR (OTIC)
600 mg in 1 mL
5/23/2025
Mylan Institutional LLC
67457-177
INTRAVESICAL
0.54 g in 1 mL
10/18/2017

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
VERRUMAL SOLUTION
SIN04266P
SOLUTION
8 g/100 g
4/30/1990

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath